Tag: vaccine

New York’s vaccine czar called county officials to gauge their loyalty to Cuomo amid sexual harassment investigation

Mary Pat Campbell

Link: https://www.washingtonpost.com/politics/cuomo-schwartz-vaccine-calls/2021/03/14/18f2e320-8448-11eb-9ca6-54e187ee4939_story.html?fbclid=IwAR1_kucY6IuuqosArhyJ203JxSha3ZcmndHtvDX6URSZod-bqCmgxCZBB0k

Excerpt:

New York’s “vaccine czar” — a longtime adviser to Gov. Andrew M. Cuomo — phoned county officials in the past two weeks in attempts to gauge their loyalty to the embattled governor amid an ongoing sexual harassment investigation, according to multiple officials.

One Democratic county executive was so unsettled by the outreach from Larry Schwartz, head of the state’s vaccine rollout, that the executive on Friday filed notice of an impending ethics complaint with the public integrity unit of the state attorney general’s office, the official told The Washington Post. The executive feared the county’s vaccine supply could suffer if Schwartz was not pleased with the executive’s response to his questions about support of the governor.

The executive said the conversation with Schwartz came in proximity to a separate conversation with another Cuomo administration official about vaccine distribution.

Author(s): Amy Brittain, Josh Dawsey

Publication Date: 14 March 2021

Publication Site: Washington Post

Federal law prohibits employers and others from requiring vaccination with a Covid-19 vaccine distributed under an EUA

Mary Pat Campbell
Federal law prohibits employers and others from requiring vaccination with a Covid-19 vaccine distributed under an EUA

Excerpt:

The same section of the Federal Food, Drug, and Cosmetic Act that authorizes the FDA to grant emergency use authorization also requires the secretary of Health and Human Services to “ensure that individuals to whom the product is administered are informed … of the option to accept or refuse administration of the product.”

Likewise, the FDA’s guidance on emergency use authorization of medical products requires the FDA to “ensure that recipients are informed to the extent practicable given the applicable circumstances … That they have the option to accept or refuse the EUA product …”

Author(s): Aaron Siri

Publication Date: 23 February 2021

Publication Site: Stat News

Russia’s Covid-19 Vaccine Is Embraced Abroad, Snubbed at Home

Mary Pat Campbell

Link: https://www.wsj.com/articles/russias-covid-19-vaccine-is-embraced-abroad-snubbed-at-home-11615200713

Excerpt:

Last summer, Russia was the first nation to announce its approval of a Covid-19 vaccine. Dozens of countries from Mexico to Iran have since ordered millions of doses of the shot, known as Sputnik V.

But at home, Russia’s vaccination campaign has sputtered in the midst of one of the world’s highest levels of vaccine hesitancy. While the vaccine is free and widely available, only 3.5% of Russians have received at least one shot, compared with 32.1% in the U.K., according to Our World in Data, a project based at Oxford University that tracks the global vaccine rollout. In the U.S., it’s about 18%. Recent surveys show that less than a third of Russians are willing to get the Sputnik V vaccine.

Behind the skepticism are lingering doubts about Sputnik V’s rapid development and an ingrained distrust of authority stemming from the country’s Soviet past. Polls show many Russians believe the coronavirus is a man-made biological weapon. At the same time, surveys indicate a strong current of Covid-19 disbelief in Russia.

Author(s): Georgi Kantchev

Publication Date: 8 March 2021

Publication Site: Wall Street Journal

How Economic Recovery Hinges on the Vaccine Rollout

Mary Pat Campbell

Link: https://knowledge.wharton.upenn.edu/article/how-economic-recovery-hinges-on-the-vaccine-rollout/?utm_source=kw_newsletter&utm_medium=email&utm_campaign=2021-03-09

Excerpt:

At the current pace of around 1.5 million doses per day, PWBM said it expects economic recovery “to continue but proceed gradually through the middle of year,” with employment rising to nearly 152 million in July and four-quarter real GDP growth of around 5% in the third quarter. Averaging over the full year of 2021, PWBM projected that raising the rate of daily vaccinations to 3 million or more would increase employment by nearly 1 million and real GDP growth by about a third of a percentage point.

The effects on the labor market that PWBM projected are largest in the summer, “which is when how quickly you’re able to vaccinate people makes the biggest difference,” said Arnon. At 2 million vaccinations a day, say, by the end of the year, most of the people who want it would have been vaccinated, he noted.

Author(s): Alex Arnon

Publication Date: 9 March 2021

Publication Site: Knowledge @ Wharton

Detroit Mayor Is Wrong To Turn Down J&J COVID-19 Vaccines

Mary Pat Campbell
Detroit Mayor Is Wrong To Turn Down J&J COVID-19 Vaccines

Excerpt:

The Detroit Free Press reports that the mayor declined to accept a shipment of 6,200 doses of the Johnson & Johnson one-shot vaccine. Why? At a press conference on Tuesday, the mayor asserted, “Johnson & Johnson is a very good vaccine. Moderna and Pfizer are the best. And I am going to do everything I can to make sure the residents of the city of Detroit get the best.”

What does the mayor mean by “best”? Duggan stated, “The Moderna and Pfizer vaccines are 95% effective if you get two shots. Johnson & Johnson is one shot, which is nicer, but it’s about 67% effective.”

Actually, in the United States arm of the Johnson & Johnson (J&J) clinical trial, the vaccine’s ability to prevent moderate to severe infection was 72 percent and it is 85 percent effective at preventing severe disease.In addition, the J&J vaccine has been shown to be effective against the new, more contagious COVID-19 variants that are now spreading across the country. And it is likely that many citizens would prefer the convenience of getting a one-and-done J&J shot as opposed to waiting nearly a month to get a second Moderna or Pfizer/BioNTech shot.

Author(s): Ronald Bailey

Publication Date: 5 March 2021

Publication Site: Reason

EU and Italy Block Export of AstraZeneca Covid-19 Vaccine to Australia

Mary Pat Campbell

Link: https://www.wsj.com/articles/eu-and-italy-block-export-of-astrazeneca-covid-19-vaccine-to-australia-11614875649?mod=djemwhatsnews

Excerpt:

Italy blocked the export of AstraZeneca PLC’s Covid-19 vaccine to Australia, in a move coordinated with European Union authorities, reflecting mounting frustration in Europe with slow deliveries of vaccines.

The move was prompted by the persisting shortage of vaccines in Italy and the EU, delays in the supply of vaccines by AstraZeneca and the fact that Australia is considered a “nonvulnerable country” to Covid-19 under EU regulations, Italy’s Ministry of Foreign Affairs said.

The decision affects 250,700 doses, a number the ministry said was high compared with what has been delivered so far by AstraZeneca. The doses were bottled at a factory near Rome that is part of the company’s supply chain. AstraZeneca has delivered around 1.5 million doses to Italy, according to the government.

Author(s): Giovanni Legorano,  Jenny Strasburg

Publication Date: 4 March 2021

Publication Site: Wall Street Journal

Canada: An Official Strong Recommendation for First Doses First

Mary Pat Campbell

Link: https://marginalrevolution.com/marginalrevolution/2021/03/canada-an-official-strong-recommendation-for-first-doses-first.html

Excerpt:

Canada’s National Advisory Committee on Immunization (NACI), a scientific advisory group to the government, has made a forceful and dramatic statement strongly favoring First Doses First (delay the second dose.) This is a very big deal for the entire world. Basically NACI have endorsed everything that Tyler and I have said on First Doses First since my first post tentatively raised the issue on December 8. I am going to quote this statement extensively since it’s an excellent summary. No indentation.

Author(s): Alex Tabarrok

Publication Date: 4 March 2021

Publication Site: Marginal Revolution

Dolly Parton gets first dose of COVID-19 vaccine she helped fund

Mary Pat Campbell

Link: https://abc11.com/10383614/

Excerpt:

Dolly Parton has received her first shot of the Moderna COVID-19 vaccine she helped fund with a $1 million donation to Vanderbilt University last year.

Parton chronicled the vaccination process in a video posted Tuesday to social media. In it, she sang a parody of her hit song “Jolene” with new lyrics imploring people to get vaccinated.

“Vaccine, vaccine, vaccine, vaccine,” she sang in the famous tune. “I’m begging of you please don’t hesitate.”

Publication Date: 2 March 2021

Publication Site: ABC 11 Eyewitness News

Only One U.S. State Has Vaccinated 10% of Its Black Population: Covid-19 Tracker

Mary Pat Campbell

Link: https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/us-vaccine-demographics.html

Graphic:

Excerpt:

Some of the disparities are a result of who has approval to get shots so far. The elderly are more likely to be White, while the Hispanic population skews young and is less likely to work in hospitals and nursing care, groups targeted in the earliest phases of vaccine distribution.

Other disparities are a result of lower uptake rates among certain groups. Some health-care settings have reported that it’s taking longer to build up trust with communities of color, particularly Black people, who are wary of a medical establishment that for centuries has ignored and mistreated them. Anti-vaxx misinformation campaigns are targeting the already hesitant, including women and Black people. In addition, those with fewer resources may not be able to navigate the notoriously buggy and overloaded online sign-up systems. Meanwhile, others with connections, time, and money can snap up open slots.

Publication Date: 24 February 2021 (last updated)

Publication Site: Bloomberg

Officials Struggle With Conflicting Vaccine Priorities

Mary Pat Campbell

Link: https://www.governing.com/now/Officials-Struggle-With-Conflicting-Vaccine-Priorities.html

Excerpt:

Though the nation’s vaccine availability will probably improve substantially in the coming months, officials at this moment are wading through what could be the most contentious phase of the rollout — a collision of relentless demand and constrained supply. “We’ve got to take care of the most vulnerable,” California Gov. Gavin Newsom said at a recent news briefing when asked about priority for individuals with disabilities and underlying conditions.

….

At the heart of the debate around how to allocate vaccines is a conundrum: Should scarce vaccine be given to one young person, say a supermarket cashier who interacts with hundreds of people a day, because that may protect five elderly people from being infected? Or should the vaccines go directly to five elderly people?

Author(s): SOUMYA KARLAMANGLA AND COLLEEN SHALBY, LOS ANGELES TIMES

Publication Date: 26 February 2021

Publication Site: Governing

Vaccine Efficacy, Statistical Power and Mental Models

Mary Pat Campbell

Link: https://zeynep.substack.com/p/vaccine-efficacy-statistical-power

Excerpt:

 If that’s what the vaccine trials were measuring—the height of thewall that is our immune system comparing vaccine effectiveness would make a lot of sense.  Many high-profile, highly-credentialed people have been (misleadingly) describing it exactly in that manner: that if a vaccine is 95% effective, those 5% are left “unprotected.” If Moderna and Pfizer and 95% efficacious, and if Johnson and Johnson is 66%—well, that would mean that 34% of the people are left “unprotected.” right?

Wrong. To get to why that assumption is not right—and why those vaccine efficacy numbers are not the height of the wall that represents the immune system—let me first mention something important The two mRNA vaccines do appear to be spectacular, but they were tested under conditions where those pesky “variants-of-concern”—the B.117 (UK one) and B. 1.351 (South Africa) and P1–were not widespread. If tested now, under equal conditions, those numbers may be closer. Plus, Johnson & Johnson is a single-shot with a trial with a booster underway. So those efficacy numbers may well be much closer in reality than they appear from the trial results. But let’s leave that aside for a moment.

Author(s): Zeynep Tufekci

Publication Date: 2 March 2021

Publication Site: Insight on Substack